Oberweis Asset Management »

Treace Med Concepts shares owned by Oberweis Asset Management

Quarter-by-quarter ownership of Treace Med Concepts (TMCI) shares owned by Oberweis Asset Management from 13F filings

Historical chart of Oberweis Asset Management investment in Treace Med Concepts

Tip: Access up to 7 years of quarterly data

All positions including Treace Med Concepts held by Oberweis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Treace Med Concepts by Oberweis Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.7M 356k 13.11
2023-06-30 $6.4M 252k 25.58
2023-03-31 $3.9M 154k 25.19

More positions owned by Oberweis Asset Management

Credo Technology Group Holding (CRDO)
Lumentum Hldgs (LITE)
Rambus (RMBS)
Ambarella (AMBA)
Sharkninja (SN)
Applied Optoelectronics (AAOI)
Encompass Health Corp (EHC)
Frontdoor (FTDR)
Adma Biologics (ADMA)
American Superconductor (AMSC)
Sportradar Group Ag Class A Ord (SRAD)
NOVA MEASURING Instruments L (NVMI)
Itron (ITRI)
SkyWest (SKYW)
Sitime Corp (SITM)

View all positions for Oberweis Asset Management

Top funds holding Treace Med Concepts

Armistice Capital
BlackRock
William Blair Investment Management
Vanguard Group
Gagnon Securities
Millennium Management
Atlantic Trust
Jpmorgan Chase & Co
First Eagle Investment Management
Geode Capital Management
State Street Corporation
Gagnon Advisors
Deutsche Bank Aktiengesellschaft
Parkman Healthcare Partners
D. E. Shaw & Co

View all funds holding Treace Med Concepts